| Name | Title | Contact Details |
|---|
Wellteq is creating the future of precision wellness through a digital wellbeing ecosystem taking users from point of prevention through to point of care. Delivered into the corporate health and insurance sector to drive user engagement through a personalised wellness journey. wellteq uses a range of data types from wearable devices, sensors, biomarkers and user-generated data that, in combination with machine learning and artificial intelligence enables individual-level insights into Stress, Fatigue, Sleep Quality, Cognitive Function and Activity levels. Behavioural science and content targeting use biometric and behavioural analytics to deliver personalised wellness insights and practical recommendations to build engagement, agency and more effective sustainable management of personal wellness. Programs are highly customisable and provide an experience packed with gamification, group projects, social interaction rewards and charity all to maximise healthy behavioural change. With customisation comes flexibility, which is paramount for businesses of all shapes and sizes around the world today.
Anhydro A/S is a Elkridge, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our seasoned hosts will help you find the experience you’re looking for. We’re here to lend a steady hand as you navigate the wondrous world of cannabis.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Systems Xcellence, Inc is a Milton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.